Dual Stimuli-Responsive Nanoparticles for Controlled Release of Anticancer and Anti-inflammatory Drugs Combination

2017 ◽  
Vol 23 (39) ◽  
pp. 9397-9406 ◽  
Author(s):  
Liandong Feng ◽  
Yuqi Wang ◽  
Zhiliang Luo ◽  
Zheng Huang ◽  
Yan Zhang ◽  
...  
2003 ◽  
Vol 400 (1-2) ◽  
pp. 227-234 ◽  
Author(s):  
Francesco Castelli ◽  
Chiara Messina ◽  
Maria Grazia Sarpietro ◽  
Rosario Pignatello ◽  
Giovanni Puglisi

2006 ◽  
Vol 308 (1-2) ◽  
pp. 168-174 ◽  
Author(s):  
Ana Rita C. Duarte ◽  
Mariana Sousa Costa ◽  
Ana Luísa Simplício ◽  
Maria Margarida Cardoso ◽  
Catarina M.M. Duarte

2016 ◽  
Vol 87 (6) ◽  
pp. 849-857 ◽  
Author(s):  
Elham Khodaverdi ◽  
Hossein Ali Soleimani ◽  
Fatemeh Mohammadpour ◽  
Farzin Hadizadeh

2014 ◽  
Vol 6 (5) ◽  
pp. 522-530 ◽  
Author(s):  
Dhanya Narayanan ◽  
Neethu Ninan ◽  
R. Jayakumar ◽  
Shantikumar V. Nair ◽  
Deepthy Menon

Planta Medica ◽  
2010 ◽  
Vol 76 (12) ◽  
Author(s):  
V Francisco ◽  
A Figueirinha ◽  
B Neves ◽  
C Garcia-Rodriguez ◽  
M Lopes ◽  
...  

1996 ◽  
Vol 16 (01) ◽  
pp. 56-59
Author(s):  
D. J. Tyrrell ◽  
C. P. Page

SummaryEvidence continues to accumulate that the pleiotropic nature of heparin (beyond its anticoagulant potency) includes anti-inflammatory activities at a number of levels. It is clear that drugs exploiting these anti-inflammatory activities of heparin may offer exciting new therapeutic applications to the treatment of a wide range of inflammatory diseases.


Sign in / Sign up

Export Citation Format

Share Document